Funding
China’s Berry Oncology Secures $99.15 Million in Series B1, Sets Industry Record for Highest Overall Capital Raised
2021-08-06
China’s Qitan Technology Raises Over RMB400 Million in Series B Funding to Develop Nanopore Gene Sequencing
2021-06-23
Japanese Biotech Raises $37 Million in Series C to Develop Stem Cell Therapy for Heart Failure
2021-06-13
MorphoSys Partners with Royalty Pharma to Fund $1.7B Constellation Pharmaceuticals Buyout
2021-06-05
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115